BUSINESS● LOWSep 23 · Sep 23, 2026, 5:19 PM
Oruka falls after updating mid-stage trial data for plaque psoriasis therapy
Seeking Alpha Tech · global
Oruka's stock has fallen following an update to its mid-stage trial data for a plaque psoriasis therapy. This indicates a negative market reaction to the trial results.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS15m agoBGFI: Henri-Claude Oyima succeeds in his bet on the stock market introduction in two phasesJeune AfriqueBUSINESS16m agoMan City charges: Maresca says club, players, fans are ‘more together’Vanguard Nigeria